About Anpac Bio

Decades of research by the world’s most respected cancer scientists and physicians consistently reveals one conclusion:

Most people can survive cancer if the disease is caught early.

This fact led Anpac Bio Co-Founders, Dr. Chris Yu and Dr. Herbert Yu, to ask the question that ultimately launched the company:

“What if we could detect cancer before tumors start?”

Achieving that goal became the Anpac Bio Co-Founders’ quest. They began breaking the problem apart—drawing on expertise in:

• Cancer research
• Bio-chemistry
• Chemistry
• Nano-technology
• Surface science
• Material science
• Detection
• Physics
• Engineering and manufacturing

Together they founded Anpac Bio-Medical Science Co., Ltd. in 2010, bringing together a multi-national team of medical, biomedical and nanotechnology scientists, and engineering experts. Their unique, cross-disciplinary approach combines numerous fields of science, medicine and engineering to achieve vastly superior early cancer screening and detection technology.

LEARN MORE